Philip Ashton-Rickardt - Insider Trading & Ownership

Entity
Individual
Location
C/O Sigilon Therapeutics, Inc., 100 Binney Street, Suite 600, Cambridge, MA
All Insider Reports
All Insider Reports

Ownership of Philip Ashton-Rickardt

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SGTX Sigilon Therapeutics, Inc. Chief Scientific Officer Aug 11, 2023

Insider Transactions Reported by Philip Ashton-Rickardt:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.